chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a health professional concerning a 53 year old male, who on 26-NOV-2007 was vaccinated intramuscularly in the left deltoid with a first dose of pneumococcal 23v polysaccharide vaccine (Lot# 658451/0963U or 658673/0990U). On 27-NOV-2007, the patient experienced swelling of the left deltoid, redness around the injection site, and pain in left deltoid. The patient was advised to place an ice pack on the injection site and to take BENADRYL, two times a day. The patient was also advised to see the doctor if the symptoms persisted. The patient recovered on an unspecified date. Additional information has been requested.
Pt. complained of pain in her eye over the weekend in October.  The Monday following the weekend she had a routine ophthalmologist appointment. It was found that her vision was far worse in the left eye than had ever been previously.  Her vision became worse over the next 2 days so we went back to the ophthalmologist and she could barely see light out of the left eye at that point much less see.  She was admitted to the hospital and had a brain and spinal MRI as well as numerous tests.  It was found that she had lesions in her brain and had optic neuritis. She was given IV steroids for 3 days and then sent home with oral steroids.  She tested positive for MOG antibodies.  We have followed up with a neuroimmunologist twice a year since the event. She has had bi-annual MRI testing and serum MOG antibody testing.  The lesions have nearly resolved and the MOG has tested negative the two times it was tested this year.  She has permanent partial damage (paleness) of the optic nerve.
Lymph glands swollen and painful from 6/6 to 6/11; Hives from 6/11 to present. Used benydril and Cotizone, but nothing seems to work.
I was already on my period when I got the shot on 9/24. My cycles are usually 28-30 days. They are on the heavier side sometimes.   I started my period 2 weeks early on 9/9 and the bleeding has been the heaviest in my life. There is significant blood loss not to mention my period is not suppose to come for another 2 weeks. I don?t take any medications or vitamins or have any underlying reason for it to be this bad.
5FEB c/o nausea/vomiting, hives, t101-tx w/DPH & APAP; 6FEB began wheezing, SOB tx w/breathing tx & inhales; 8FEB wheezing persisted-breathing tx inhalers;
No additional AE; Medical assistant reported ROTATEQ  was administered after temperature excursion. See full details below. No additional AE/no PQC.  ?    Names of vaccines involved ROTATEQ 1968393 05/24/2024 ?    Temperature 8.9°C (08/14/2023) and 9.4°C (08/28/; This spontaneous report was received from a medical assistant and refers to a unknown patient.  The patient's medical history, concurrent conditions and concomitant therapies were not reported.  On 14-AUG-2023, the patient was vaccinated with rotavirus vaccine, live, oral, pentavalent (ROTATEQ) oral liquid, 1 dose, lot #1968393, expiration date: 24-MAY-2024, administered for prophylaxis (strength, and route of administration were not provided). This vaccine underwent temperature excursion in 8.9 degree Celsius for 12 hours 20 minutes (Product storgae error) and in 9.4 degree Celsius fo 8 hours 20 minutes (confilicting information due to administration on 14-AUG-2023 and temperature excursion on 28-AUG-2023). No additional adverse event was reported.
Pt. recieved vaccine greater than 12 hours after being drawn up. MD contacted pt. no adverse event. pt. declines revaccination.
Post vaccine, began having chest pains (next day) at football practice. They continued with any physical exertion. He was seen in the ED on Friday and given a steroid shot. He continues to have chest pain with any exertion.
5 cm, circular reddened.  left thigh.  slightly warm to the touch.  does not appear to be painful  benadryl and tylenol given for pain and discomfort
June 6th - I got sick. I talked to my doctor and I had a test done on Friday - negative result for COVID. My daughter in law had home tests. I was positive  for COVID on Sunday - Sunday was when I had the symptoms. I had a scratchy throat; I didn't feel good. It felt like a building fell on me with not feeling good. I didn't get out of bed too much for the first three days. Fourth day, I was still no energy but I got up and showered. . I talked to doctor on Monday (video call). He said I had the Delta Variant - I was sick for 4 days. I still have cough and low energy. I am without fever. My vitals - I got a blood pressure cuff - and oxygen monitor - my levels stayed where they needed to be without going to ER. I also developed a UTI infection (not tested but based on symptoms) which added to my being sick - I developed that on my fifth day. I got medication for that. After the 14 days, (got a negative test after the two weeks) - at Beaumont Urgent Care in Dearborn. I work from home and I still didn't feel good to do that. I still have the cough but not as bad. My energy level is not good - I have to take a nap after work. For COVID I was given to take Zinc and Vit D and I took OTC ThoroughFLU.
Patient received first 2 doses of Moderna Covid Vaccine. Patient has Rheumatoid Arthritis and currently takes Embrel Sureclick injection for RA. Patient requested for 3rd dose of Covid vaccine. This RN gave 3rd dose of Pfizer in error. Patient tolerated well. Patient was informed about the error and is fine with it.
Received T/C from patient.  States received Flu vaccine on Monday, September 14, 2009 in left deltoid.  States immediately felt a pain in her left side of neck.  Did not report to the nurse who admninistered the vaccine.  States did not have any pain at injection site or redness.  No pain down her arm.  No numbness or tingling in her arm.  No other signs/symptoms.  States is improving.  Has done no OTC treatment, i.e ice/heat, meds.
Mild pox on face, body, legs and hairline. No mediation, Aveena bath, Calamine lotion + Benadryl PRN. Pt received vaccine at another PMD manufacturer & lot # unavailable to us.
Information has been received from a physician concerning a healthy 51 year old male with no past medical history who on 06-June 2000 was vaccinated with one dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) ( manufacturer unknown).  There was no concomitant medication.  On 18 June 2000, the patient developed utricaria, server hives and angloedema which was still present on 30 Jun 2000 except when on disphenhydramine (Benadryl).  The reporter noted that the patient was negative for hepatitis, had normal thyroid function and no other allergies.  The patient sought unspecified medical attention.  Additional information has been requested.
Muscle pain on injection site radiating to shoulders; Redness on injection site,  rash-like, slightly raised
REDNESS AROUND INJECTION SITE, THAT BY DAY AFTER THE INJECTION EXPANDED TO COVER THE WHOLE UPPER ARM AND AROUND THE WHOLE UPPER ARM, WITH UPPER ARM BEING 30-40% INCREASE IN SIZE, ITCHING.
Shortly after receiving the vaccine patient reported feeling like he was going to pass out. Assisted patient to the first aid station so he could lay down on the cot. After 15 minutes of lying down the patient felt back to normal. Vitals taken. Patient then sat in waiting area for an additional 15 minutes and then he felt well enough to leave.
This case was reported by a consumer via call center representative and described the occurrence of injection site cellulitis in a 60-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. On 21st September 2021, the patient received the 1st dose of Shingrix (intramuscular) 50 ug. On an unknown date, less than 3 months after receiving Shingrix, the patient experienced injection site cellulitis, injection site erythema, injection site swelling and injection site pain. The patient was treated with antibiotics NOS. On an unknown date, the outcome of the injection site cellulitis was recovered/resolved and the outcome of the injection site erythema and injection site swelling were unknown and the outcome of the injection site pain was not recovered/not resolved. It was unknown if the reporter considered the injection site cellulitis, injection site erythema, injection site swelling and injection site pain to be related to Shingrix. The case was self reported by the patient. The patient received Shingrix in left arm and experienced a red, swollen arm, and cellulitis. The reporter stated that, the redness and soreness in left arm started gradually after the 1st dose and after 4 days she went to the urgent care and had to receive antibiotics for the treatment of cellulitis in her arm (resolved). Cellulitis was confirmed to have occurred in the same arm where the vaccine was received. The reporter also stated that, till the day of reporting her arm was still sore. The reporter could not provide the lot or expiration date of Shingrix vaccine. The reporter consented to follow up by phone. The reporter consented to contact her healthcare professional. For the tolerance of 2nd dose, refer case US2021AMR252661, reported by the same reporter.; Sender's Comments: US-GLAXOSMITHKLINE US2021AMR252661:Same reporter.
This spontaneous report was received from a nurse refers to a 01-year-old patient of unknown gender. The patient's relevant medical history, concurrent conditions, concomitant medications, drug reactions or allergies were not reported. On 15-SEP-2017, the patient was vaccinated with improperly stored VAQTA lot # N008823, expiry date: 26-MAY-2018, and M-M-R II lot # M045392, expiry date: 17-NOV-2018; dosing details were not reported, both for prophylaxis. The lot of M-M-R II was reconstituted with properly stored sterile diluent (MRK). No adverse effects were reported. Temperature excursion was from 0 degree Celsius (C) to 1 degree C (0.8 degree C) for 52 minutes. The previous temperature excursion was reported as from 9 degree C to 25 degree C (10.9 degree C) for 3 hours 17 minutes. The call was because of a data logger. No product quality complaint involved. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1709USA000054.
Chest pain after the 2nd dose of the Moderna Covid Vaccine; This spontaneous case was reported by an other health care professional and describes the occurrence of CHEST PAIN (Chest pain after the 2nd dose of the Moderna Covid Vaccine) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CHEST PAIN (Chest pain after the 2nd dose of the Moderna Covid Vaccine). At the time of the report, CHEST PAIN (Chest pain after the 2nd dose of the Moderna Covid Vaccine) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medications were provided by the reporter. No Treatment Information was provided by the reporter.   This case was linked to (E2B Linked Report).; Sender's Comments: This case concerns a 46-year-old female, with no medical history, who experienced the unexpected event of Chest pain. The event of Chest pain occurred on an unknown day after receiving the second dose of the Moderna COVID-19 Vaccine. The rechallenge was not applicable. No more doses are expected for this patient. The benefit-risk relationship is not affected by this report. Case ID:AE-2021-14813
swollen thing on her Injection area; injection area has redness that is bigger than the inject site; it hurts a little bit; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE SWELLING (swollen thing on her Injection area), INJECTION SITE ERYTHEMA (injection area has redness that is bigger than the inject site) and INJECTION SITE PAIN (it hurts a little bit) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-May-2021, the patient experienced INJECTION SITE SWELLING (swollen thing on her Injection area), INJECTION SITE ERYTHEMA (injection area has redness that is bigger than the inject site) and INJECTION SITE PAIN (it hurts a little bit). At the time of the report, INJECTION SITE SWELLING (swollen thing on her Injection area), INJECTION SITE ERYTHEMA (injection area has redness that is bigger than the inject site) and INJECTION SITE PAIN (it hurts a little bit) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported.  Treatment information was not provided.
Patient presented day after vaccine with bruising on raised area at injection site. She was recommended to get BENADRYL in case reaction was allergy related and to apply ice as needed to decrease swelling and bruising.
Patient received his first dose of Moderna on 2/4/2021 at approx 1300.  Patient called on 2/5/2021 stating he had some tongue numbness and eye swelling about 30 minutes after the injection.  He did not seek emergency care, did not take any OTC medications. Phone call to patient 2/8/2021 he states on his ride home after the first injection he noticed that the top of his tongue became numb and he developed some swelling around the edge of my eyes and the back of my tongue felt thick.  He went home and took a nap. When he woke up, he felt great.  No swelling around eyes, tongue was not numb nor did it feel thick any longer.  Patient tells me he has had a reaction like this before to a chemo enhancing medication, he does not remember the name. Patient states he still wants to receive the second dose.
Day 1 of vaccination - itching, chills, body aches, vomiting through day 3. Day 4 - redness, warm to touch.
Patient had previously been given 2 doses of Pfizer.  Was given booster dose (0.25ml) of Moderna although she doesn't turn 18 for 3 months.
This is a spontaneous report from a contactable other hcp (patient). A 40-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 2 via an unspecified route of administration, administered in left arm on 11Jan2021 10:45 (Batch/Lot number was not reported) at the age of 40 years old, as 2ND DOSE, SINGLE DOSE, and dose 1 via an unspecified route of administration, administered in left arm on 23Dec2020 10:30 (Batch/Lot number was not reported) as 1ST DOSE, SINGLE DOSE for COVID-19 immunization. Medical history included mild hypertension and exposure to an unvaccinated person who became COVID positive. The patient was not pregnant at the time of vaccination. There were no concomitant medications. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive any other medications within 2 weeks of vaccination. On 01May2021 07:00 AM, the patient had a breakthrough infection and was found to be COVID positive on 03May2021. It was a mild to moderate infection. The patient was exposed to an unvaccinated person who became COVID positive. The event resulted in Doctor or other healthcare professional office/clinic visit and Emergency room/department or urgent care. Treatments received which included Tylenol, fluticasone propionate, omeprazole. The patient was recovering from the events. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient underwent Nasal swab/RT-PCR test for COVID-19 on 03May2021 and tested positive. The events were reported as non-serious by the reporter.  Information on the lot/batch number has been requested.
Message received from PA at urgent care facility. Pt presented Thursday 12/3 for cellulitis. Spoke with nurse at clinic. Reported patient had "softball-sized" cellulitis at the injection site of her Tdap injection from 12/2. Pt given antibiotics and instructed to return to urgent care on 12/5 for reevaluation of wound.
hives & itching all over + swelling of hands that comes and goes (Right hand worse) - started ~2pm 4/10/19 & got worse. Pt's allergist advised that he take prednisone & benadryl & go to ER if got worse. Pt was able to control the Rxn. w/ benadryl & prednisone but still had some itching & fatigue + sweating after taking.
Information was received from a 64 year old male patient who is a health care professional, who, 10 years ago, at the age of 54, received a dose of influenza virus vaccine trivalent, types A &B, Flu Shield. Ten days following administration of the vaccine, he experienced pain and numbness on the right side of his face. The symptoms lasted for 6 weeks. No treatment was prescribed. No further information was available at the time of this report.
Patient received Menactra vaccine 4/23/08 @6:45pm in right Deltoid. Called the office 4/25/08 with complaints of redness, swelling and pain at injection site. Patient came back to the office 4/25/08 @ 1:45pm with a 4cm indurated, redness over site. Treated with Amoxil 500mg TID for 7 days and Benadryl 50 mg. prn.
I received my second dose at 12:15pm on 03/06/2021. By about 9-10pm I began feeling chills. I went to bed and my body wouldn?t warm up under the covers. I woke up around 1:16am feeling very hot. I was running a fever of about 102F. After removing the covers and using a cold compress it dropped to the 99F range and fluctuated quickly between about 98.7F-99.9F. I continued to have chills and feel very cold during this fluctuation. When I would stand to go to the bathroom my body would be very weak and I would get almost lightheaded.  I fell asleep by about 3:30am. The following morning my fever was completely resolved. I continued to feel weak during the first half of the day with some mild intermittent nausea. By the second half of the day my side effects resolved entirely.
10hrs post vaccine thru 60 hours had fever, chills, body& muscle aches, and a sinus-like vise grip type headache. 24 hrs post vaccine, developed severe muscular lower back pain. Took tylenol starting after 24 hours which reduced but did not eliminate symptoms.  3 days post vaccine, started to develop ear ringing on right side, which is now worse on day 4. Still have minor residual lower back soreness and stiffmeck.
I had several days of headaches with a sore throat and felt a little ran down in the 4-5 days before testing positive. 1/25/2023 I woke up and felt like I was hit by a truck, I felt bad and body aches. No fever. Symptoms lasted about 2 days and then were greatly diminished, mostly just soreness. Televisit on 1/25, after testing positive on an at home COVID-19 test. Doctor prescribed PAXLOVID.
shingles; This case was reported by a other health professional via call center representative and described the occurrence of shingles in a 79-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received on an unknown date).   On 6th July 2019, the patient received the 2nd dose of Shingrix. On 12th July 2019, 6 days after receiving Shingrix, the patient experienced shingles. On an unknown date, the outcome of the shingles was not recovered/not resolved.   It was unknown if the reporter considered the shingles to be related to Shingrix.  Additional details were provided as follows: This case was reported by the office manager. The batch number was not available due to the patient received the vaccine elsewhere. At the time of reporting, the patient had symptoms. The reporter consented to follow up.
eczema flare at modenra vaccine injection site; Fear of needles; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE ECZEMA (eczema flare at modenra vaccine injection site) and FEAR OF INJECTION (Fear of needles) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for Prophylactic vaccination.     Previously administered products included for Atopic dermatitis: DUPIXENT (Solution for injection, 150 mg/mL Dose: 300 mg Frequency: QOW Route: Subcutaneous Exp. date: 30Apr2022) on 24-Oct-2019, DUPIXENT on 24-Oct-2019 and DUPIXENT on 24-Oct-2019. Past adverse reactions to the above products included Intentionally missed dose with DUPIXENT; Therapy interrupted with DUPIXENT; and Treatment nonadherence with DUPIXENT.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE ECZEMA (eczema flare at modenra vaccine injection site) and FEAR OF INJECTION (Fear of needles). At the time of the report, VACCINATION SITE ECZEMA (eczema flare at modenra vaccine injection site) and FEAR OF INJECTION (Fear of needles) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient was off dupixent for more than 4 weeks and poor adherence to dupixent while being treated with dupilumab [Dupixent] with the use of dupilumab pre filled syringe and COVID-19 vaccine MRNA (MRNA 1273) [moderna COVID-19 vaccine].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  No concomitant medications were reported.  It was not reported if the patient received a corrective treatment for the events.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.
Question: We would be happy to help you, please let us know what condition this follow up message is regarding. Answer: I had a flu shot and a pneumonia shot in the office 9/27/13 and wanted the reaction I had entered into my chart. Unfortunately, as I had 2 shots, we can't know which one or the combination caused my reaction. By the evening of 9/27, my left arm (where I had the shots) ached intensely from shoulder to neck and down through my hand. It hurt to put deodorant on. By 9/28 a painful, non-itching raised red rash ran from the injection in a wide band to my armpit. It left completely 10/1. On 9/29, I remembered a herpes outbreak I had 7 years ago on the same hand and lower arm which was very similar so I upped my acyclovir which I take daily. Very possibly, that is what got rid of the reaction so quickly. Question: When was your last appointment for this condition with your doctor? Answer: Less than 7 days ago Question: How may we help you? Answer: Just put the reaction in my chart so I don't forget about it when I have my flu shot next year.  Question: If your doctor would like to prescribe a medication for you, please provide the name and the location or address of the pharmacy where you would like to pick up your medication. Answer: No med. necessary.
Initial consumer report received on 16 Dec 2009: This patient's medical condition included autoimmune disorder.  The patient received FLUVIRIN (batch no. unknown) on 03 Nov 2009.  Within one week after vaccination, she experienced tingling in her hands, arms, feet and legs.  She also experienced fatigue, myalgia, diarrhea and constipation.  Neurologist diagnosed polyneuropathy and prescribed Neurontin 300 mg TID and Elavil 10 mg daily.  She would be visiting her current neurologist but also planning to seek second opinion from "more specialized neurologist".  Her symptoms were unchanged.  Following internal review on 08 Jan 2010 of the information received on 16 Dec 2009 polyneuropathy was considered medically significant and hence upgraded.  Following internal review on 14 Apr 2010 of the data received on 16 Dec 2009, it was noted that suspect vaccine was incorrectly reported as FLUVIRIN.  The correct suspect vaccine was H1N1 (manufacturer and batch number unknown).
Left arm has ongoing aching and pain, especially in the deltoid area. Much worse with cold weather. Continues now, 5 years later.
Itching and burning body wide, achiness, pain and itching at injection site, headache.